Skip to main content
For VC funds, family offices, angel groups and bank funding teams

Your team can’t diligence every deal. Aventro can.

Reads the deck, checks every claim against the official register, scores the company, models the exit.

Twenty minutes on a deal you already know. No pitch.

~5 minUpload to a scored assessment
40Decks in a single drop

Companies on Aventro

Partner logoPartner logoPartner logoGOLLDY LTDGlypho

Diligence is expensive, so most deals never get any.

Whether you see forty deals a year or a thousand, the full workup goes to a few and the rest are passed on blind. The industry’s own numbers:

500–1,000
Companies the average partner sees in a yearVenture Capital Careers
30–50
Of those that get deep due diligenceVenture Capital Careers
118 hrs
What one real diligence pass costs, on average4Degrees

Aventro runs the institutional pass on every deal you see, whether that is forty a year or forty a week.

Step 01

The deal arrives

A deck, a data pack, or a founder submission. Nothing to reformat, and no template imposed on anyone.

Step 02

Claims are checked

Each claim is matched against the register it should appear in. Official records outrank aggregators, which outrank the open web.

Step 03

Your team decides

Flags, gaps, and a decision-support verdict. The call, and the memo, stay yours.

Forty decks. One ranked table.

Drop the whole inbound at once. Every deck comes back analysed, scored and ranked.

  • Up to 40 decks in a single drop
  • Pull the decks straight from Google Drive or Dropbox
  • Analysis needs nothing from the founder
  • Verdict, readiness and expected MOIC on every row
  • Invite the founders worth taking further, in bulk

Q3 Inbound· 38 decks · ranked by score

Live
CompanyVerdictScore

Northwind Bio

Health

Meets criteria81

Corvia Labs

Deep tech

Meets criteria76

Tessel AI

SaaS

Considerations68

Halden Robotics

Hardware

Considerations61

Orrery Systems

SaaS

Does not meet47

Meridian Health

Health

Does not meet39

Vantor Grid

Climate

Considerations55

Bluewater Labs

Biotech

Does not meet44

Deck drop

≈5 min a deck

38 of 38 analysed

Claims checked
312
Flagged
3
From founders
0

Next step, in bulkInvite top 12 founders

14 modules. Your weights.

A generic weighting is someone else’s thesis.

  • 11 weighted modules; 3 more run for context
  • Module and sub-factor weights set per organisation
  • Every score opens to sub-factors, then evidence, then the page
  • What-ifs recompute through the same chain
Team & Execution
14%
Market & Timing
11%
Competitive Landscape
11%
Traction & Growth
11%
Market Capture
9%
Unit Economics
9%
IP & Defensibility
9%
Failure Correlation (RIP)
8%
Go-to-Market
7%
Financial Health
6%
Consistency Check
5%

The exit maths, on every deal.

Five scenarios, an expected MOIC, and the multiple that returns the fund.

  • Implied ownership and graduation-weighted dilution, per round
  • Base rates drawn from 19 dated, named publications
  • Re-anchored to the deal's own revenue and sector
  • No model call anywhere in this code path

Deterministic, and labelled as such in the report. Decision support, never a recommendation.

Northwind Bio· Series A · Exit & Returns

Live

Expected MOIC

2.4x

Probability-weighted

Time to liquidity

7–9 yrs

Sector median

Ownership at exit

9.6%

After modelled dilution

Cheque modelled

$1.5M

This round, this deal

ScenarioProbabilityMultiple
Failure54%0.0x
Downside19%0.9x
Base17%3.2x
Upside8%9.4x
Home run2%28.0x

Computed deterministically · no model call in this path

Return the fund

11.6x

Needed at this cheque · every base rate cited

Ask your whole portfolio a question.

It reads every deal you can reach before it answers.

  • Find every deal with an unresolved red flag
  • Search founders across the whole portfolio
  • Ask what changed since last quarter
  • It acts too: open a request, run a simulation

Portfolio· 12 companies

Live
CompanyVerdictScore

Northwind Bio

Health

Meets criteria81

Corvia Labs

Deep tech

Meets criteria76

Tessel AI

SaaS

Considerations68

Halden Robotics

Hardware

Considerations61

Orrery Systems

SaaS

Does not meet47

Meridian Health

Health

Does not meet39

Which deals still have unresolved red flags?

Three of twelve.

Orrery SystemsPatent claim matched no register record

Meridian HealthRevenue in deck ≠ revenue in filings

Tessel AITwo team claims still unverified

Open an evidence request to each founder…

Your IC memo, filled in.

Upload the template your committee uses. The deal data fills it and hands it back in your format.

  • Your template and your format, exactly as uploaded
  • A Word file comes back as a Word file
  • A fill report names every slot it could not answer
  • A one-page summary, decision fields ready to sign
  • Your firm's mark on anything you pass to an LP

Committee memo· Your template

Live
Company overviewNorthwind Bio, Series A, oncology diagnostics out of Haifa…
Round & valuation$6.0M at $32M post, 19 months of runway at plan…
Team assessmentTwo technical founders, prior exit in diagnostics…
Expected return2.4x expected MOIC across five scenarios…
Legal & counsel notes

The fill report names every slot it could not answer, rather than guessing.

IC-Memo-template.docx

5 answerable slots detected

.docx in, .docx out

The questions your partners will ask.

Answered before you are in the room.

“An LLM scoring startups is a black box.”

Every section is labelled with how it was produced, every score opens to its evidence, and every source we query is published with its authority tier.

  • Valuation and returns contain no model call at all
  • Per-section provenance labels on the report and the PDF
  • The full source list is public, not on request

“It will substitute for our judgement.”

The output is Investment Decision Support: Meets Readiness Criteria, Proceed with Considerations, or Does Not Meet Criteria. It never recommends an investment.

  • Disclaimers sit inline, ahead of every decision block
  • The same wording in the web report and the exported PDF
  • The call, and the memo, stay yours

“Where does our deal data live?”

Evidence is encrypted per deal with AES-256-GCM. Access is per deal and per person, and private deals are visible only to named viewers.

  • A full JSON export, at any time, without asking
  • DPA available and the subprocessor list published
  • A security audit trail that is answerable during an incident
Aventro presents everything I need clearly in one place. It makes the analysis easier to navigate and will significantly reduce the time needed to review an opportunity.
Anonymous reviewer · Investment Analyst, Israeli VC & Crowdfunding Platform
This is genuinely impressive - kudos. The report instantly clarified our gaps and strengths, and gave me actionable next steps for investor readiness.
Yuval Marom · Founder, Juntos

Priced to your portfolio.

Quoted on seats and deal volume. An extra company costs nothing to run.

For investment teams: an annual contract, priced to seats and deal volume. Quoted on a call.

5 min
From upload to a scored, evidence-checked assessment
44
Independent sources cross-checked, official registers first
11
Weighted scoring modules, each traced back to its evidence
  • Seats, roles, and per-deal access
  • Forty decks in one cohort drop
  • Portfolio analytics across every deal
  • Exit and returns on every deal
  • Custom scoring weights and benchmarks
  • Your own IC memo template, filled
  • Chat across your whole portfolio
  • Per-deal AES-256-GCM encryption

Raising a round? Founder Readiness $200 · Investor Readiness $350 · Fundraising Decision Pack $700, one time.

Founder packs

Frequently asked questions

Everything you need to know about Aventro.

From claims to conviction.

Bring one live deal. Twenty minutes later you have the full pass: what checks out, what does not, and what we got wrong. No pitch.

Raising a round instead? Founders start free, no credit card.Aventro for founders